Medical Research

The best starting point in treating PCOS? It’s not Clomid.

To say that PCOS is a huge problem is a real understatement. It affects 6 - 8 % of women, and it’s the most common reason for anovulatory infertility (more than 80% of cases)!

For a long time, Clomiphene Citrate (usually prescribed as Clomid) has been a standard first line drug used to induce ovulation in PCOS. But there’s a big gap in how often Clomid makes women ovulate (about 85% of the time), versus how often it leads to pregnancy (35-40% of the time). It’s hypothesized that this may be because of adverse effects Clomid has on the endometrium and cervical mucus.

A few years ago, a Cochrane systematic review reported that Letrozole (brand name Femara) had a 44% higher pregnancy rate thank Clomid for PCOS women, but the quality of the evidence wasn’t convincing at the time.

New Study: Clomid vs. Femara


Now, a recent study with a much better design has tried to answer the question: which is a better first line ovulation induction method for anovulatory PCOS women -- Clomiphene Citrate (Clomid) or Letrozole (Femara)? They compared ovulation rates, pregnancy, live birth, and more. We’ll spell out more details below, but at a very high level, Femara looked much better than clomid on just about every meaningful outcome.

Study Design


The good news: this was a randomized controlled trial, and it was blinded, meaning the women and the doctors didn’t know which drug they were on. This was a group of 159 women aged 18 - 39 years old, with BMIs of 35 or less. All of them were not ovulating and met the definition of PCOS based on the Rotterdam criteria (which means at least 2 of: anovulation, hyperandrogenaemia, and polycystic ovaries on ultrasound).

Treatment was continued until pregnancy or 6 ovulatory cycles, at which point, if they weren’t pregnant, they were crossed over to the other drug as a secondary option. If they didn’t respond to either treatment earlier, they also had the option to take a 6 week break then cross over.

The Important Stuff: What the Study Showed


Femara showed a significantly higher pregnancy rate than Clomid -- the rate was 61%, which was 40% higher than clomid’s rate of 43%. For patients with a BMI less than 30, the pregnancy rates were even higher, at 68.6% of patients getting pregnant with Femara, and 46.9% on Clomid.

As we all know, the time to pregnancy is important, and women got pregnant on Femara faster than they did on Clomid (with median cycles of 4 cycles on femara vs. 6 cycles on Clomid before pregnancy).

Live birth rate, of course, is the most important metric. In this respect, Femara showed a strong trend towards superiority, with a rate of 40% more than clomid. The absolute live birth rates were 49.3% for Femara and 35.1% for Clomid, but it’s important to note that while this trend was very strong, there wasn’t a big enough group in the study to show the result with statistical significance (the P value was 0.079).

As far as maternal and neonatal complication rates, there appeared to be no difference. There also weren’t enough people in the study to show a meaningful difference in the twin rate.

Results for the Crossover Group


For women who didn’t respond to either Clomid or Femara, then switched over, there was a relatively low pregnancy rate for both drugs as secondary treatments. The authors raise the possibility that this could indicate a cross-resistance between the two drugs.

Study Limitations


The main limitation to this study is the size -- we really wish they’d had more patients so that some of the most important findings and indicators (like the live birth rate) met statistical significance instead of just showing strong trends.

Also, the study was conducted in Europe, on a predominantly caucasian patient base, with a small group of South Asian women, so it’s not fully representative for a US population.

Overall, though, this was a strong study design, with findings that will likely be helpful to many doctors and patients as they contemplate the first line treatment for inducing ovulation amongst PCOS patients.

Expert's Perspective
Dr de Ziegler's Guide To Endometriosis

Dr. de Ziegler breaks down the misconceptions around surgery being the only way to diagnose endometriosis, weighs in on the decision between IVF and endometriosis surgery, and much more.

Expert's Perspective
When Is The ERA Test Appropriate?

The Endometrial Receptivity Assay is a test used by clinicians to discern when an embryo should be transferred to the uterus. The developmental state of the embryo and the uterine lining must be in sync for the embryo to implant. Here we look at the theory behind the ERA's usefulness and what the data implies about who, if anyone, should have the test performed.

Expert's Perspective
Treating East Asian Women For Infertility

East Asian women may metabolize estorgen differently and this may be the reason their rates of success tend to lag those of Caucasian women. This may add insight on the woman's choice of a fresh versus frozen transfer or how much gonadatropins to take.

Expert's Perspective
How We Might Treat South Asian Women Differently

As a field we're beginning to appreciate that women of different ethnicities may require unique treatment to achieve comparable outcomes. Here, Stanford professor Val Baker eluciates some of the nuances in treating women of a South Asian background.

Expert's Perspective
How Long Are Frozen Eggs and Embryos Good For?

IVF treatment is a relatively new treatment, and egg and embryo freezing are newer still. So do we know how long these gametes can be safely stored and still work?

Expert's Perspective
The Male Fertility Evaluation: Enhances Options and Signals of Future Health

20 - 25% of U.S. couples annually undergo IVF without having the male partner properly checked. This drives tens of thousands of unnecssary treatments, as well as needless cost and suffering. What's more, bypassing this crucial step causes us to miss a vital signal into that man's future health.

Expert's Perspective
Is it safe to ship cryopreserved eggs (and embryos)?

Patients are increasingly eager to ship their eggs and embryos to clinics out of town, out of state and out of the country. Vitrification has made that a far more delicate process. Peter Nagy, Ph.D helps explain the outcomes, steps and costs associated with shipping gametes from one clinic to another.

Expert's Perspective
Freeze Eggs or Embryos?

When the option to freeze embryos is available to patients, many disregard the option to freeze eggs. Owen Davis, ASRM President, weighs in on why egg freezing is still an important option to consider.

Expert's Perspective
From MacBooks to MAC Cosmetics: How Our Daily Routine Impacts Fertility

Dr. Cooper lays out the evidence on the products & habits that harm fertility, and realistic steps we can take to protect ourselves

Expert's Perspective
Improving IVF Success Rates: Using Low Oxygen in the Lab

Selecting a clinic is as much about selecting their laboratory as anything else. A key determinant of lab quality is the conditions they use to culture embryos. Using low oxygen in the incubator is preferable, yet a third of laboratories don't do this.

Expert's Perspective
Early Pregnancy Loss

Early pregnancy loss is the only focus of the team at Montefiore-Einstein in NYC. Here are some of their high-level observations on how to deal with the medical challenges.

+ Show More Articles
Personal Story
What We Never Expected About Reciprocal IVF

Christina and her wife Katie decided to bulid their family using Reciprocal IVF. Christina walks us through what turned out how they expected, and what didn't -- including the financial costs, choosing sperm donors, IVF success (and failure), recognition by the state, and having the outside world accept them as equal mothers.

Personal Story
Getting it Together After the Diagnosis: Making a Plan With Your Partner

Laura and her wife Sam always presumed they would need treatment to have a child, but the news Laura had fertility issues came as a surprise. Over the course of multiple cycles, and multiple years, they learned a number of crucial lessons.

Personal Story
Marriage & Male Infertility: Not on the Same Page and That’s O.K.

Men and women often deal differently with the emotional impact of infertility. How important is it for us to see everything the same way?

Personal Story
Twiblings: Being Pregnant During Surrogacy

Some hopeful mothers fear that having a child through surrogacy will be less special or intimate. For those who wonder, meet Nancy Rohde, who carried her own child, and had a baby through surrogacy, at the same time.

Personal Story
Wrangling With Reduction

Many patients undergoing fertility treatment ultimately need to grapple with the notion of whether it is safe to have a multiple pregnancy. Katie Ferraro talks about her decision not to selectively reduce during her quadruplet pregnancy.

+ Show More Articles
Medical Research
What Mosaicism Means for Live Birth Rates

New data compares results transferring different types of mosaic embryos, with surprising outcomes.

Medical Research
IUI Success Rates Doubled With Endometrial Scratch

Medicated IUI success rates remain stubbornly low with live birth rates often around 10% per cycle. Investigators determined whether incorporating endometrial scratch bolsters IUI success rates. For the moment, it appears so.

Medical Research
The Impact of Sugar, Soda and Caffeine on IVF

The team at Brigham & Women's Hospital in Boston reveals surprising results on how sugar, soda and caffeine each impact (or don't) oocyte numbers and ultimate IVF success rates.

Medical Research
CRISPR, Gene Editing and IVF

Gene-editing in IVF made a big breakthrough this month and the CRISPR technology is now a reality. Here we catch up with Paula Amato and the team from Oregon Heath Sciences behind latest breakthrough.

Medical Research
Weight Loss and IVF

The average American woman has a BMI in the high 20's. So for women undergoing IVF, with a BMI in the low-mid 30's, does weight loss improve rates of success? A team from Sweden ran a thoughtfully-conducted trial that offers up surprisingly complex answers.

Medical Research
IUI or IVF For Unexplained Infertility

Roughly 30% of infertility cases are labeled "unexplained," so how should patients decide between IUI vs IVF when we don't know the underlying issue? Here's one clue for a narrow subset of the newly-diagnosed "unexplained" population.

Medical Research
Does Your Clinic Influence If Your Embryos Are Good

Theoretically, the quality of your eggs and sperm should determine the quality of your embryos. However, this month we're reviewing data that shows which clinic you go to, and how they care for you and your embryos, could be a crucial determinant.

Medical Research
When IVF Babies Grow Up, Are They Healthy?

An Israeli study rigorously followed up with adults who were conceived via IVF, and compared their cognitive function, medical and mental health with naturally conceived peers. This is a unique study focusing on the long-term health of IVF babies and adults.

Medical Research
When One IVF Cycle Completes All Your Family Building Goals

For some IVF patients a single cycle can deliver two children through two pregnancies. For many Americans, two children is the ideal number. So who are the best candidates for "one-and-done" IVF in a safe and responsible manner?

Medical Research
Why It Matters Which Doctor Performs Your IVF Transfer

According to FertilityIQ data, 70% of patients have a different doctor perform their transfer. Scott Morin and Eric Forman of RMA New Jersey study to what extent that matters.

+ Show More Articles